CardiaTec raises $6.5M Seed for cardiovascular drug discovery

This was originally published on post
CardiaTec is decoding the biology behind cardiovascular disease using high-dimensional human multi-omics data to navigate complex disease biology better and identify novel and differentiated therapeutics.